Hidroferol® — Competitive Intelligence Brief

Hidroferol® (Hidroferol®) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin D analog. Area: Endocrinology / Metabolic disorders.

marketed Vitamin D analog Vitamin D receptor (VDR) Endocrinology / Metabolic disorders Small molecule

Target snapshot

Hidroferol® (Hidroferol®) — Hospital Universitario de Canarias. Hidroferol is a vitamin D analog that activates vitamin D receptors to regulate calcium and phosphate metabolism and modulate immune function.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Hidroferol® TARGET	Hidroferol®	Hospital Universitario de Canarias	marketed	Vitamin D analog	Vitamin D receptor (VDR)
Dovonex	CALCIPOTRIENE		marketed	Vitamin D Analog [EPC]	Vitamin D3 receptor	1993-01-01
cholecalciferol (vitamin D3)	cholecalciferol (vitamin D3)	Medical University of South Carolina	marketed	Vitamin D analog / Secosteroid	Vitamin D receptor (VDR)
Calcitriol (Rocaltrol®)	Calcitriol (Rocaltrol®)	Joslin Diabetes Center	marketed	Vitamin D analog	Vitamin D receptor (VDR)
Alfarol 1.0 µg	Alfarol 1.0 µg	Eli Lilly and Company	marketed	Vitamin D analog	Vitamin D receptor (VDR)
Eldecalcitol capsules	Eldecalcitol capsules	Shanghai Jiao Tong University Affiliated Sixth People's Hospital	marketed	Vitamin D analog	Vitamin D receptor (VDR)
doxercalciferol capsules, Hectorol®	doxercalciferol capsules, Hectorol®	Genzyme, a Sanofi Company	marketed	Vitamin D analog	Vitamin D receptor (VDR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

• 2026-05-26 — Dovonex · 8629128 · Formulation · US
• 2028-05-07 — Dovonex · 8263580 · Formulation · US

Sponsor landscape (Vitamin D analog class)

1. LEO Pharma · 2 drugs in this class
2. Genzyme, a Sanofi Company · 2 drugs in this class
3. National Cancer Institute, Naples · 2 drugs in this class
4. OPKO Health, Inc. · 2 drugs in this class
5. Joslin Diabetes Center · 1 drug in this class
6. Kyowa Kirin, Inc. · 1 drug in this class
7. Maimónides Biomedical Research Institute of Córdoba · 1 drug in this class
8. Shanghai Jiao Tong University Affiliated Sixth People's Hospital · 1 drug in this class
9. Shiraz University of Medical Sciences · 1 drug in this class
10. St. Justine's Hospital · 1 drug in this class